August 09, 2022 at 9:12 pm
Atara Biotherapeutics (ATRA) Jumps Up Almost 30% As They Announce Strategy Update
Atara Biotherapeutics (ATRA) shot up almost 30% today as they announced their Q2 update and restructuring plans. ATRA will be reducing cash burn by laying off 20% of their staff, providing a significant boost to their cash runway, which will now last until Q1, 2024. The Company also plans on refocusing its R&D operations. The… [Read More]